PYC Therapeutics | PYC - Ebitda

Aktienkurs
1.50
Täglich Wechseln
0.01 0.67%
Monatlich
0%
Jährlich
21.54%
Q1 Prognose
1.46




Ebitda Veränderung Datum
Avita Medical AUD -9.69M 12.21M 2025-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Pacific Edge NZD -13.97M 332K 2024-09
Paradigm Biopharmaceuticals AUD -5.86M 3.79M 2024-12
Telix Pharmaceuticals AUD 18.42M 14.82M 2025-12